Tagomics announces a multiomic profiling co-marketing agreement with Agilent

Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis

Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line

Strategic agreement will accelerate the manufacturing of fully human multispecific therapies for chronic retinal diseases with high unmet need using Asimov’s CHO Edge System

Steritas announces collaboration with argenx to advance evidence for novel steroid-sparing therapeutics

First-in-class steroid-toxicity outcome assessments licensed by argenx to support development of novel steroid-sparing therapeutics for autoimmune diseases

Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis

Paper in the European Journal of Medicinal Chemistry discloses the optimisation process leading to the selection for development of ETD001, an inhaled ENaC blocker with a best-in-class profile ETD001 commenced Phase 2 clinical study in people with cystic fibrosis in Jul

The importance of choosing sustainable accommodation for winter travel

Winter is a time for cosy getaways, snowy adventures, and festive experiences, but it’s also a season that puts added pressure on the environment. Increased energy use for heating, high water demand, and waste generation can make winter travel a challenging time to be eco-friendly. One of the most impactful ways to reduce your environmental footprint during the winter months is by choosing…

Sapio Sciences collaborates with Waters Corporation to improve efficiency of laboratory operations

The advanced connectivity of Sapio LIMS with waters_connect for Quantitation liquid chromatography mass spectrometry (LC-MS) software

ARU is investigating link between fat and cancer

New research is being funded by US-based charity Colorectal Cancer Alliance.

Mursla Bio’s EvoLiver surpasses current standards in liver cancer surveillance, data presented at AASLD Liver Meeting 2024

EvoLiver™ demonstrated 86% early-stage sensitivity at 88% specificity for liver cancer surveillance among cirrhotic, high-risk patients with diverse etiologies Validates clinical value of multi-omics content in organ-specific extracellular vesicles for liver cancer d

First ever UK-wide project launched to explore the inequality in access to psychological care within childhood brain tumour services

A pilot year-long project studying the inequality in access to psychological care within childhood brain tumour services, and the implications on access to clinical trials, has been launched by a team at the Great North Children’s Hospital in Newcastle. The project has been funded by children’s brain tumour charity, Tom’s Trust.

CMS’ Alzheimer’s NCD: Outlier or harbinger of increased scrutiny?

Aduhelm was the first FDA-approved disease-modifying treatment for Alzheimer’s, sparking debate among providers, regulators, and patients.

Analytics for clinical development strategy: Integrated optimization of an oncology program

Achieving a return on invested capital (ROIC) that exceeds the cost of capital remains a challenge for pharmaceutical R&D. To make progress, there needs to be consistent and rigorous modeling of the clinical and commercial determinants of ROIC.

Cleancube Multi: Guardtech Group’s shipping container facilities helping NHS Aseptic Pharmacies MOVE forward

Suffolk contamination control experts’ award-winning Cleancube Mobile Cleanrooms proving to be perfect solution for Trusts that require facility upgrades

Cambridge Psychosis Centre offers specialist advice for complex cases

CPFT experts have launched a new service providing specialist advice and guidance with research to help people living with severe mental health conditions schizophrenia and psychosis.

CN Bio launches PhysioMimix Bioavailability assay kit: Human 18

Unique solution enabling researchers to profile human oral drug bioavailability in vitro, in their own laboratories Expands access to CN Bio’s robust multi-organ Gut/Liver-on-a-chip model to accelerate and de-risk clinical progression of drug candidates

Sphere Fluidics strengthens global commercial teams and establishes direct sales and support channel in North America

Significant expansion of global commercial leadership team led by new CEO, Dale Levitzke, to address global demand for the Cyto-Mine Chroma platform

Cambridge, UK, 14th November 2024: Sph

Primerdesign launches new animal multiplex assays at London Vet Show

Rapid, accurate detection of six gastrointestinal disease-causing pathogens in cats and dogs.

Keytruda LoE: A seismic shift for oncology?

Immune checkpoint inhibitors (ICIs) have changed the face of oncology treatment since their initial entry in the early 2010s. Driven mostly by the group of PD-1 and PD-L1 molecules, they have resulted in cumulative 2023 global revenues exceeding $45 billion USD.

AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States

AstraZeneca announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs contributing to the growth of the US economy.

Appointment of new Vice President of Sales and Marketing at Lucida Medical

We are pleased to announce the appointment of Corina Cucuruzac as Vice President of Sales and Marketing at Lucida Medical, effective immediately. With a distinguished career in the MedTech industry across various fields, Corina brings deep expertise in driving growth, building strong customer relationships, and leading successful commercial strategies.

100 guests including local sixth form students attend International Men's Day talks and wellbeing workshop at SBC

We were delighted to welcome over 100 guests to International Men’s Day at Stevenage Bioscience Catalyst.

Claire Nicholls joins Salus Wellness Clinics

We are excited to welcome Claire Nicholls to Salus Wellness this month.

Bio-Rad demonstrates leadership position in the oncology market at Association for Molecular Pathology 2024

Strength of ddPCR™ Products, Including IVDR Certification, Strategic Collaborations in Molecular Residual Disease Monitoring, and Large Methylation Assay Library, Support Company’s Oncology Strategy

Parkwalk and Cambridge Enterprise launch tenth University of Cambridge Enterprise Fund

Cambridge, November 2024 - Parkwalk Advisors, in collaboration with Cambridge Enterprise, is proud to announce the launch of the University of Cambridge Enterprise Fund X (UCEF X).

Mursla Bio joins leading European consortium to advance clinical applications based on extracellular vesicle science

Selected to support scaling and commercialization strategy for extracellular vesicle-based disease surveillance and diagnostics Consortium funded by Horizon Europe, the largest European research and innovation program

Cambridge, UK, and Bo

WaveFX transforms Lisbon into a live streaming hub

WaveFX has just returned from a week in Portugal, filming and live streaming for EACTS (European Association for Cardio-Thoracic Surgery). This prestigious scientific event stands as the largest global gathering for the cardiothoracic community, drawing thousands of delegates from around the world. With such a diverse audience, it was the perfect opportunity to showcase innovations and…